| Bioactivity | Fosbretabulin (tromethamine), also known as combretastatin A4 phosphate (CA4P), is a vascular disrupting agent evaluated for its efficacy against anaplastic thyroid carcinoma (ATC). It targets tumor neovasculature, causing acute and reversible reductions in tumor blood flow and central necrosis[1]. |
| CAS | 404886-32-4 |
| Formula | C22H32NO11P |
| Molar Mass | 517.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Fosbretabulin tromethamine
CAS: 404886-32-4 F: C22H32NO11P W: 517.46
Fosbretabulin (tromethamine), also known as combretastatin A4 phosphate (CA4P), is a vascular disrupting agent evaluated
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.